Jacobs Levy Equity Management, Inc Omeros Corp Transaction History

Jacobs Levy Equity Management, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 17, 2020	SELL	$12.21 - $16.99 $1.35 Million - $1.88 Million	-110,701 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$9.03 - $19.72 $586,661 - $1.28 Million	-64,968 Reduced 36.98%	110,701 $1.48 Million
Q4 2019 Feb 14, 2020	BUY	$13.01 - $17.15 $1.31 Million - $1.73 Million	100,900 Added 134.95%	175,669 $2.48 Million
Q3 2019 Nov 14, 2019	BUY	$14.55 - $20.56 $1.09 Million - $1.54 Million	74,769 New	74,769 $1.22 Million

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $762M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.